Medplus Subsidiary Faces License Suspensions in Andhra Pradesh Following Regulatory Actions
Medplus Health Services Limited has reported that its subsidiary, Optival Health Solutions Private Limited, has received two suspension orders concerning Drug Licenses for stores operating within the state of Andhra Pradesh. The regulatory actions resulted in a temporary halt to operations at two specific locations.The suspensions were issued by different authorities following alleged contraventions of Rule 65 of the Drugs and Cosmetics Act, 1940 and the related Rules, 1945. Both orders were received on June 23, 2026.
One suspension pertains to a store located at Kovvada Main Road in Rajamahendravaram, East Godavari District, Andhra Pradesh. Another concerns a store situated at Bethemcherla Main Road within the jurisdiction of Kurnool and Nandyal Districts, also in Andhra Pradesh. Both licenses were suspended for seven days.
The details regarding the regulatory actions and associated impacts are summarized below:
| Authority Name | Location | Action Taken | Date Received | Potential Revenue Loss |
|---|---|---|---|---|
| Assistant Director & District Sales Licencing & Enforcement Authority, Rajamahendravaram | Kovvada Main Road, Andhra Pradesh | Suspension of Drug License for seven days | 23.06.2026 | Rs 1.92 lacs |
| Assistant Director, District Sales licensing Authority, Kurnool & Nandyal District | Bethemcherla Main Road, Andhra Pradesh | Suspension of Drug License for seven days | 23.06.2026 | Rs 1.00 lacs |
The combined potential revenue loss related to these two license suspensions is quantified as Rs 2.92 lacs.
MEDPLUS Stock Price Movement
Medplus Health Services Limited posted a solid close today, with the stock rising 0.62% to reach ₹841.95. The equity settled within its intraday range of ₹834.15 and ₹846.35, trading on a volume of 90,298 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.